Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
16 "Hyun Kyung Chung"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Articles
Thyroid
Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association Guidelines
Eu Jeong Ku, Won Sang Yoo, Hyun Kyung Chung
Endocrinol Metab. 2023;38(4):381-391.   Published online August 8, 2023
DOI: https://doi.org/10.3803/EnM.2023.1778
  • 3,088 View
  • 462 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFPubReader   ePub   
Subclinical hypothyroidism (SCH) is characterized by elevated thyroid-stimulating hormone (TSH) and normal free thyroxine levels. The Korean Thyroid Association recently issued a guideline for managing SCH, which emphasizes Korean-specific TSH diagnostic criteria and highlights the health benefits of levothyroxine (LT4) treatment. A serum TSH level of 6.8 mIU/L is presented as the reference value for diagnosing SCH. SCH can be classified as mild (TSH 6.8 to 10.0 mIU/L) or severe (TSH >10.0 mIU/L), and patients can be categorized as adults (age <70 years) or elderly (age ≥70 years), depending on the health effects of LT4 treatment. An initial increase in serum TSH levels should be reassessed with a subsequent measurement, including a thyroid peroxidase antibody test, preferably 2 to 3 months after the initial assessment. While LT4 treatment is not generally recommended for mild SCH in adults, it is necessary for severe SCH in patients with underlying coronary artery disease or heart failure and it may be considered for those with concurrent dyslipidemia. Conversely, LT4 treatment is generally not recommended for elderly patients, regardless of SCH severity. For those SCH patients who are prescribed LT4 treatment, the dosage should be personalized, and serum TSH levels should be regularly monitored to maintain the optimal LT4 regimen.

Citations

Citations to this article as recorded by  
  • Clinical Implications of Different Thyroid-Stimulating Hormone (TSH) Reference Intervals between TSH Kits for the Management of Subclinical Hypothyroidism
    Won Sang Yoo
    Endocrinology and Metabolism.2024; 39(1): 188.     CrossRef
Close layer
Thyroid
Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape
Won Sang Yoo, Hyun Kyung Chung
Endocrinol Metab. 2021;36(3):500-513.   Published online June 18, 2021
DOI: https://doi.org/10.3803/EnM.2021.1066
  • 9,216 View
  • 552 Download
  • 16 Web of Science
  • 22 Crossref
AbstractAbstract PDFPubReader   ePub   
Subclinical hypothyroidism (sHypo) is defined as normal serum free thyroid hormone levels coexisting with elevated serum thyroid-stimulating hormone (TSH) levels. sHypo is a common condition observed in clinical practice with several unique features. Its diagnosis should be based on an understanding of geographic and demographic differences in biochemical criteria versus a global reference range for TSH that is based on the 95% confidence interval of a healthy population. During the differential diagnosis, it is important to remember that a considerable proportion of sHypo cases are transient and reversible in nature; the focus is better placed on persistent or progressive forms, which mainly result from chronic autoimmune thyroiditis. Despite significant evidence documenting the health impacts of sHypo, the effects of levothyroxine treatment (LT4-Tx) in patients with sHypo remains controversial, especially in patients with grade 1 sHypo and older adults. Existing evidence suggests that it is reasonable to refrain from immediate LT4-Tx in most patients if they are closely monitored, except in women who are pregnant or in progressive cases. Future research is needed to further characterize the risks and benefits of LT4-Tx in different patient cohorts.

Citations

Citations to this article as recorded by  
  • THYROID FUNCTION ABNORMALITIES IN PATIENTS WITH CHOLELITHIASIS: A HOSPITAL-BASED CROSS-SECTIONAL STUDY
    AVANISH KUMAR SAXENA, ANAM FATIMA, KUNDRAPU VEERA VENKATA SIVA, ANUSHKA PARIYA, VAYALAPALLI SYAMA CHINMAYI
    Asian Journal of Pharmaceutical and Clinical Research.2024; : 138.     CrossRef
  • Subclinical hypothyroidism and clinical outcomes after cardiac surgery: A systematic review and meta-analysis
    Michele Dell’Aquila, Camilla S. Rossi, Tulio Caldonazo, Gianmarco Cancelli, Lamia Harik, Giovanni J. Soletti, Kevin R. An, Jordan Leith, Hristo Kirov, Mudathir Ibrahim, Michelle Demetres, Arnaldo Dimagli, Mohamed Rahouma, Mario Gaudino
    JTCVS Open.2024; 18: 64.     CrossRef
  • The Relationship between Subclinical Hypothyroidism and Carotid Intima-Media Thickness as a Potential Marker of Cardiovascular Risk: A Systematic Review and a Meta-Analysis
    Oana-Maria Isailă, Victor Eduard Stoian, Iuliu Fulga, Alin-Ionut Piraianu, Sorin Hostiuc
    Journal of Cardiovascular Development and Disease.2024; 11(4): 98.     CrossRef
  • Variability of Thyroid Hormones in Newborns from Mothers with Endemic Goiter
    Turdieva Shokhida Tolkunovna, Ganieva Durdona Kamalovna
    Journal of Nature and Science of Medicine.2024; 7(2): 129.     CrossRef
  • Thyroid dysfunction in the ageing patient
    O.V. Bilookyi, V.L. Vasiuk, O.A. Shupik
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(2): 143.     CrossRef
  • Hormonal influences on cerebral aneurysms: unraveling the complex connections
    Zahra Hasanpour Segherlou, Mahdieh Shakeri, Armin Khavandegar, Sara Stephenson, Kimberly Ciccone, Forough Masheghati, Mohammad Reza Hosseini Siyanaki, Mac Lyerly, Brandon Lucke-Wold
    Expert Review of Endocrinology & Metabolism.2024;[Epub]     CrossRef
  • Subclinical hypothyroidism, outcomes and management guidelines: a narrative review and update of recent literature
    Bogumila Urgatz, Salman Razvi
    Current Medical Research and Opinion.2023; 39(3): 351.     CrossRef
  • Indicator of thyroid hormones in newborns from mothers with diffuse-endemic goiter
    G. T. Makhkamova, Sh. T. Turdieva
    Meditsinskiy sovet = Medical Council.2023; (1): 212.     CrossRef
  • Diagnóstico y tratamiento del hipotiroidismo subclínico en adultos mayores
    Debbie Noelia Tebanta Albán, Gabriel Aníbal Hugo Merino, María Valentina Muñoz Arteaga, Ariana Lisseth Vázquez López
    Ciencia Digital.2023; 7(1): 6.     CrossRef
  • 2023 Korean Thyroid Association Management Guidelines for Patients with Subclinical Hypothyroidism
    Hyun Kyung Chung, Eu Jeong Ku, Won Sang Yoo, Yea Eun Kang, Kyeong Jin Kim, Bo Hyun Kim, Tae-Yong Kim, Young Joo Park, Chang Ho Ahn, Jee Hee Yoon, Eun Kyung Lee, Jong Min Lee, Eui Dal Jung, Jae Hoon Chung, Yun Jae Chung, Won Bae Kim, Ka Hee Yi, Ho-Cheol Ka
    International Journal of Thyroidology.2023; 16(1): 32.     CrossRef
  • Gut microbiota short-chain fatty acids and their impact on the host thyroid function and diseases
    María José Mendoza-León, Ashutosh K. Mangalam, Alejandro Regaldiz, Enrique González-Madrid, Ma. Andreina Rangel-Ramírez, Oscar Álvarez-Mardonez, Omar P. Vallejos, Constanza Méndez, Susan M. Bueno, Felipe Melo-González, Yorley Duarte, Ma. Cecilia Opazo, Al
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Human amnion-derived mesenchymal stem cells improve subclinical hypothyroidism by immunocompetence mediating apoptosis inhibition on thyroid cells in aged mice
    Chuyu Li, Qiang Rui, Xiaohan Dong, Song Ning, Jing Zhou, Huimin Wu, Chunyan Jiang, Yugui Cui, Jiayin Liu, Jun Jiang, Lianju Qin
    Cell and Tissue Research.2023; 394(2): 309.     CrossRef
  • Is Thyroid Dysfunction Associated with Unruptured Intracranial Aneurysms? A Population-Based, Nested Case–Control Study from Korea
    Hyeree Park, Sun Wook Cho, Sung Ho Lee, Kangmin Kim, Hyun-Seung Kang, Jeong Eun Kim, Aesun Shin, Won-Sang Cho
    Thyroid®.2023; 33(12): 1483.     CrossRef
  • The Role of Global Longitudinal Strain in Subclinical Hypothyroid Patients With Heart Failure
    Nismat Javed, Vibha Hayagreev, Angel DeLaCruz, Muhammad Saad, Amandeep Singh, Timothy Vittorio
    Cureus.2023;[Epub]     CrossRef
  • Association between shift work and the risk of hypothyroidism in adult male workers in Korea: a cohort study
    Seonghyeon Kwon, Yesung Lee, Eunhye Seo, Daehoon Kim, Jaehong Lee, Youshik Jeong, Jihoon Kim, Jinsook Jeong, Woncheol Lee
    Annals of Occupational and Environmental Medicine.2023;[Epub]     CrossRef
  • Estimation of left ventricular functions in patients with subclinical hypothyroidism: a meta-analysis
    Binyi Li, Yong Huang, Zheng Li
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Comparison of Five Different Criteria for Diagnosis of Subclinical Hypothyroidism in a Large-Scale Chinese Population
    Yan-song Zheng, Sheng-yong Dong, Yan Gong, Jia-hong Wang, Fei Wang, Qiang Zeng
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Subclinical Hypothyroidism and Cognitive Impairment
    Jung-Min Pyun, Young Ho Park, SangYun Kim
    Journal of Alzheimer's Disease.2022; 88(2): 757.     CrossRef
  • Effect of Levothyroxine Supplementation on the Cardiac Morphology and Function in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-analysis
    Xichang Wang, Haoyu Wang, Qiuxian Li, Ping Wang, Yumin Xing, Fan Zhang, Jiashu Li, Zhongyan Shan
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(9): 2674.     CrossRef
  • Natural history of subclinical hypothyroidism and prognostic factors for the development of overt hypothyroidism: Tehran Thyroid Study (TTS)
    A. Amouzegar, M. Dehghani, H. Abdi, L. Mehran, S. Masoumi, F. Azizi
    Journal of Endocrinological Investigation.2022; 45(12): 2353.     CrossRef
  • Retrospective cohort analysis comparing changes in blood glucose level and body composition according to changes in thyroid‐stimulating hormone level
    Hyunah Kim, Da Young Jung, Seung‐Hwan Lee, Jae‐Hyoung Cho, Hyeon Woo Yim, Hun‐Sung Kim
    Journal of Diabetes.2022; 14(9): 620.     CrossRef
  • Long working hours and the risk of hypothyroidism in healthy Korean workers: a cohort study
    Yesung Lee, Woncheol Lee, Hyoung-Ryoul Kim
    Epidemiology and Health.2022; 44: e2022104.     CrossRef
Close layer
Original Article
The Incidence of Thyroid Autoantibody in Subacute Thyroiditis and the Clinical Characteristics of Greeping Thyroiditis.
Jae Seok Jeon, Won Bae Kim, Hae Young Park, Young Joo Park, Hyun Kyung Chung, Sang Jeon Choi, Chan Soo Shin, Kyoung Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee, Chang Soon Koh
J Korean Endocr Soc. 1996;11(4):438-446.   Published online November 7, 2019
  • 1,264 View
  • 30 Download
AbstractAbstract PDF
Background
Subacute thyroiditis is a spontaneously resolving inflammatory disorder of thyroid gland, usually associated with painful goiter and short-lived thyrotoxicosis. Although its etiology is yet to be established, much evidence suggests viral infections and genetic factors play important roles. Usually, both lobes of thyroid gland are involved simultaneously, but in some patients one lobe is involved first and the other later(creeping thyroiditis), Thyroid autoantibodies which might appear probably due to inflammatory release of thyroid antigens, are found in a variable number of patients with subacute thyroiditis. However there have been few detailed reports on their incidence in Korean patients with subacute thyroiditis. So, we were to see the elinical characteristics of patients with subacute thyroiditis with special regards to the incidence of thyroid autoantibodies and to the incidence and characteristics of creeping thyroiditis, Methods: We reviewed the clinical records of 85 patients with subacute thyroiditis(7 men and 78 wornen, meam age of 43+9 years) who had visited the thyroid clinic in Seoul National University Hospital between 1986 and 1994. Results: At initial visit, the incidenees of thyroid autoantibodies were as follows: anti- microsomal antibody 7.8%, anti-thyroglobulin antibody 22.1%, and thyratropin binding inhibitor inununglobulin 6.3%. During the follow-up period, thyroid autoantibodies appeared most frequently between the first and the second month after initial visit. Compared to those with non-creeping thyroiditis, the patients with creeping thyroiditis(21.4%) had nonspecific systemic sy~rnptoms more frequently(89% vs. 42%, p<0.05). They required steroid therapy more ftequently(89% vs. 52%, p <0.05), and needed longer duration of treatment(9.3+6.2weeks vs, 4.7+3.7weeks, p<0.05). The incidence of abnormalities in liver function and the incidence of thyroid autoantibodies were higher in non-creeping thyroiditis group. Conclusion: In accordance with previous reports, thyroid autoantibodies were detected in only a small portion of Korean patients with subacute thyroiditis. Rather different clinical manifestations and different incidences of thyroid autoantibodies between ereeping group and non-creeping group suggest differences in the pathogenetic mechanisms between those two groups. However, there is need for further study to validate such observation and to elucidate the mechanisms.
Close layer
Review Article
Thyroid
Recent Advances in Autoimmune Thyroid Diseases
Won Sang Yoo, Hyun Kyung Chung
Endocrinol Metab. 2016;31(3):379-385.   Published online August 26, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.3.379
  • 5,960 View
  • 124 Download
  • 31 Web of Science
  • 33 Crossref
AbstractAbstract PDFPubReader   

Autoimmune thyroid disease (AITD) includes hyperthyroid Graves disease, hypothyroid autoimmune thyroiditis, and subtle subclinical thyroid dysfunctions. AITD is caused by interactions between genetic and environmental predisposing factors and results in autoimmune deterioration. Data on polymorphisms in the AITD susceptibility genes, related environmental factors, and dysregulation of autoimmune processes have accumulated over time. Over the last decade, there has been progress in the clinical field of AITD with respect to the available diagnostic and therapeutic methods as well as clinical consensus. The updated clinical guidelines allow practitioners to identify the most reasonable and current approaches for proper management. In this review, we focus on recent advances in understanding the genetic and environmental pathogenic mechanisms underlying AITD and introduce the updated set of clinical guidelines for AITD management. We also discuss other aspects of the disease such as management of subclinical thyroid dysfunction, use of levothyroxine plus levotriiodothyronine in the treatment of autoimmune hypothyroidism, risk assessment of long-standing antithyroid drug therapy in recurrent Graves' hyperthyroidism, and future research needs.

Citations

Citations to this article as recorded by  
  • A Mendelian randomization study of the effect of serum 25-hydroxyvitamin D levels on autoimmune thyroid disease
    Yunfeng Yu, Xinyu Yang, Jingyi Wu, Xueli Shangguan, Siyang Bai, Rong Yu
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Therapeutic Potential of CRISPR/Cas in Hashimoto's Thyroiditis: A Comprehensive Review
    Apoorva Upreti, Sayali Mukherjee
    Current Gene Therapy.2024; 24(3): 179.     CrossRef
  • Salenio: clinical study design
    Domenico Parmeggiani, Paola Bassi, Maddalena Claudia Donnarumma, Chiara Colonnese, Vincenzo Ieluzzi, Laura Pacca, Chiara Agresti, Massimo Agresti
    Endocrinology&Metabolism International Journal.2023; 11(1): 1.     CrossRef
  • Medical Applications of Molecular Biotechnologies in the Context of Hashimoto’s Thyroiditis
    Maria Trovato, Andrea Valenti
    Diagnostics.2023; 13(12): 2114.     CrossRef
  • IMMUNOHISTOCHEMICAL CHARACTERISTICS OF THYROID GLAND CHANGES IN PATIENTS WITH AUTOIMMUNE THYROIDITIS
    F. G. Sadikhov
    World of Medicine and Biology.2023; 19(84): 139.     CrossRef
  • The C55A Single Nucleotide Polymorphism in CTLA-4 Gene, a New Possible Biomarker in Thyroid Autoimmune Pathology Such as Hashimoto’s Thyroiditis
    Alin-Dan Chiorean, Mihaela Laura Vica, Ștefana Bâlici, Gheorghe Zsolt Nicula, Nicoleta Răcătăianu, Mădălina Adriana Bordea, Laura-Mihaela Simon, Horea Vladi Matei
    Diagnostics.2023; 13(15): 2517.     CrossRef
  • USING LASER PHOTODYNAMIC THERAPY IN THE TREATMENT OF AUTOIMMUNE THYROIDITIS
    F. G. Sadikhov
    World of Medicine and Biology.2023; 19(85): 166.     CrossRef
  • Autoimmune thyroiditis in different age groups and subjects of reproductive age in Adzhariya population
    N. G. Tchelidze, S. Z. Glonti, D. Sh. Baratashvili, N. O. Kedelidze, J. Yu. Ungiadze, I. I. Nakashidze
    Obstetrics, Gynecology and Reproduction.2022; 16(1): 8.     CrossRef
  • Alterations and Mechanism of Gut Microbiota in Graves’ Disease and Hashimoto’s Thyroiditis
    Hong Zhao, Lijie Yuan, Dongli Zhu, Banghao Sun, Juan Du, Jingyuan Wang
    Polish Journal of Microbiology.2022; 71(2): 173.     CrossRef
  • The association of six autoimmune bullous diseases with thyroid disorders: a population‐based study
    K. Kridin, F. Hübner, R. Linder, E. Schmidt
    Journal of the European Academy of Dermatology and Venereology.2022; 36(10): 1826.     CrossRef
  • Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications
    Meropi Karakioulaki, Dedee F. Murrell, Aikaterini Kyriakou, Aikaterini Patsatsi
    International Journal of Women’s Dermatology.2022; 8(3): e053.     CrossRef
  • Best Achievements in Translational and Basic Thyroidology in 2020
    Sun Wook Cho, Young Joo Park
    Endocrinology and Metabolism.2021; 36(1): 36.     CrossRef
  • Incidence and Clinical Implications of Autoimmune Thyroiditis in the Development of Acne in Young Patients
    Laura Endres, Delia Mirela Tit, Simona Bungau, Nicoleta Anamaria Pascalau, Laura Maghiar Țodan, Erika Bimbo-Szuhai, Gabriela Mariana Iancu, Nicoleta Negrut
    Diagnostics.2021; 11(5): 794.     CrossRef
  • Attaining Euthyroidism - Seal the Loopholes
    Payel Biswas, Subhankar Chatterjee
    International Journal of Thyroidology.2021; 14(1): 69.     CrossRef
  • Cardiac Autonomic Modulation and Anti-Thyroid Peroxidase (TPO) Antibodies in Subclinical Hypothyroidism – Does Any Correlation Exist?
    Manisha Mavai, Dr Bharti Bhandari , Anish Singhal, Sandeep K Mathur
    Cureus.2021;[Epub]     CrossRef
  • Sensibilidade ao glúten e tireoidite de Hashimoto: uma interação viável
    Larissa Barros Pinto Franco, Fernanda Neves Pinto, Claudia Teresa Bento, Carla Viana Dendasck
    Revista Científica Multidisciplinar Núcleo do Conhecimento.2021; : 110.     CrossRef
  • Chronic urticaria and thyroid pathology
    Sandra Nora Gonzalez-Diaz, Mario Sanchez-Borges, Diana Maria Rangel-Gonzalez, Rosa Ivett Guzman-Avilan, Jose Ignacio Canseco-Villarreal, Alfredo Arias-Cruz
    World Allergy Organization Journal.2020; 13(3): 100101.     CrossRef
  • Genome-Wide Analysis Identifies Two Susceptibility Loci for Positive Thyroid Peroxidase and Thyroglobulin Antibodies
    Antonela Matana, Thibaud Boutin, Vesela Torlak, Dubravka Brdar, Ivana Gunjača, Ivana Kolčić, Vesna Boraska Perica, Ante Punda, Ozren Polašek, Maja Barbalić, Caroline Hayward, Tatijana Zemunik
    The Journal of Clinical Endocrinology & Metabolism.2020; 105(3): 944.     CrossRef
  • Iodine and bromine in fish consumed by indigenous peoples of the Russian Arctic
    Nikita Sobolev, Andrey Aksenov, Tatiana Sorokina, Valery Chashchin, Dag G. Ellingsen, Evert Nieboer, Yulia Varakina, Elena Plakhina, Alexandra Onuchina, Magny Skinlo Thomassen, Yngvar Thomassen
    Scientific Reports.2020;[Epub]     CrossRef
  • Significance of arsenic and lead in Hashimoto's thyroiditis demonstrated on thyroid tissue, blood, and urine samples
    Aleksandar Stojsavljević, Branislav Rovčanin, Jovana Jagodić, Danijela Drašković Radojković, Ivan Paunović, Marija Gavrović-Jankulović, Dragan Manojlović
    Environmental Research.2020; 186: 109538.     CrossRef
  • Prognostic Value of Caspase-1, Interleukin-1β, Tumor Necrosis Factor-α and Interleukin-18 Activity in Patients with Gastroesophageal Reflux Disease and Autoimmune Thyroiditis
    T. M. Pasiieshvili, O. M. Kovaloyva, L. M. Pasiieshvili , N. M. Zhelezniakova
    Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2020; 5(4): 202.     CrossRef
  • A historical excursus of diagnostic methods for Hashimoto thyroiditis and Graves' disease
    Maria Trovato
    Gazzetta Medica Italiana Archivio per le Scienze Mediche.2020;[Epub]     CrossRef
  • The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma
    Eyun Song, Hye‐Seon Oh, Min Ji Jeon, Ki Wook Chung, Suck Joon Hong, Jin Sook Ryu, Jung Hwan Baek, Jeong Hyun Lee, Won Gu Kim, Won Bae Kim, Young Kee Shong, Tae Yong Kim
    International Journal of Cancer.2019; 144(6): 1414.     CrossRef
  • Hydatid cyst of the thyroid gland with tracheal fistula: A case report and review of the literature
    Tiemin Jiang, Qiang Guo, Bo Ran, Ruiqing Zhang, Tuerganaili Aji, Yingmei Shao
    Experimental and Therapeutic Medicine.2019;[Epub]     CrossRef
  • Thyroid diseases and skin autoimmunity
    Enke Baldini, Teresa Odorisio, Chiara Tuccilli, Severino Persechino, Salvatore Sorrenti, Antonio Catania, Daniele Pironi, Giovanni Carbotta, Laura Giacomelli, Stefano Arcieri, Massimo Vergine, Massimo Monti, Salvatore Ulisse
    Reviews in Endocrine and Metabolic Disorders.2018; 19(4): 311.     CrossRef
  • Does severe vitamin D deficiency impact obstetric outcomes in pregnant women with thyroid autoimmunity?
    Halenur Bozdag, Esra Akdeniz
    The Journal of Maternal-Fetal & Neonatal Medicine.2018; : 1.     CrossRef
  • Constitutive Changes in Circulating Follicular Helper T Cells and Their Subsets in Patients with Graves’ Disease
    Yan Liu, Xinwang Yuan, Xiaofang Li, Dawei Cui, Jue Xie
    Journal of Immunology Research.2018; 2018: 1.     CrossRef
  • Comorbidity of autoimmune thyroid disorders and psychiatric disorders during the postpartum period: a Danish nationwide register-based cohort study
    V. Bergink, V. J. M. Pop, P. R. Nielsen, E. Agerbo, T. Munk-Olsen, X. Liu
    Psychological Medicine.2018; 48(8): 1291.     CrossRef
  • Spontaneous conversion from Graves’ disease to Hashimoto’s thyroiditis: a case report
    Muharrem Bayrak, Kenan Çadırcı, Emine Kartal Baykan, Ünsal Aydın, Ayşe Çarlıoğlu
    Ortadoğu Tıp Dergisi.2018; 10(1): 81.     CrossRef
  • Role of T Follicular Helper (Tfh) Cells Plasticity in Autoimmune Thyroiditis among Hepatitis C Virus Infection
    Helal F Hetta
    Gastroenterology & Hepatology: Open Access.2017;[Epub]     CrossRef
  • Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease
    Rong-hua Song, Qian Li, Wen Wang, Qiu-ming Yao, Xiao-qing Shao, Jin-an Zhang
    International Journal of Endocrinology.2017; 2017: 1.     CrossRef
  • Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia
    Clodoveo Ferri, Michele Colaci, Poupak Fallahi, Silvia Martina Ferrari, Alessandro Antonelli, Dilia Giuggioli
    Frontiers in Endocrinology.2017;[Epub]     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
Close layer
Editorial
Environmental Factors and Thyroid Dysfunction.
Hyun Kyung Chung
Endocrinol Metab. 2012;27(3):191-193.   Published online September 19, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.3.191
  • 1,790 View
  • 19 Download
  • 3 Crossref
AbstractAbstract PDF
No abstract available.

Citations

Citations to this article as recorded by  
  • A study on the health effects of residents in Namhae and Hadong - Centered on health insurance data
    YoonDeok Han, Sunghyeon Jung, Kwang-tae Ha, Seung-Mi Kwon, Seog-Ju Cho, Jin-Ho Sin, Yong-Seung Shin, Bu-Soon Son
    Journal of Odor and Indoor Environment.2020; 19(3): 268.     CrossRef
  • Cost-of-Illness Trends Associated with Thyroid Disease in Korea
    Kyung-Rae Hyun, Sungwook Kang, Sunmi Lee
    Endocrinology and Metabolism.2014; 29(3): 257.     CrossRef
  • The Biochemical Prognostic Factors of Subclinical Hypothyroidism
    Myung Won Lee, Dong Yeob Shin, Kwang Joon Kim, Sena Hwang, Eun Jig Lee
    Endocrinology and Metabolism.2014; 29(2): 154.     CrossRef
Close layer
Letter
Letter: The Association between Type 2 Diabetes Mellitus and Colorectal Cancer.
Hyun Kyung Chung
Endocrinol Metab. 2011;26(4):364.   Published online December 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.4.364
  • 50,295 View
  • 19 Download
AbstractAbstract PDF
No abstract available.
Close layer
Case Reports
Reversible Heart Failure and Rhabdomyolysis Caused by Primary Hypoparathyroidism during Lactation.
Kyongyeun Jung, Jeong Hyun Choi, Hee Jin Kim, Hyun Kyung Chung, Dohee Kim
Endocrinol Metab. 2011;26(3):268-271.   Published online September 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.3.268
  • 1,683 View
  • 26 Download
AbstractAbstract PDF
Hypocalcemia can be complicated, on rare occasions, by congestive heart failure and may also be associated with labor and lactation in some cases. Herein, we report a 30-year-old woman with hypocalcemia-induced heart failure secondary to primary idiopathic hypoparathyroidism precipitated by lactation. The patient presented with chest pain and paresthesia in both arms and legs during breast-feeding after her second delivery. She had severe hypocalcemia and low parathyroid hormone levels. Hypocalcemia-induced rhabdomyolysis further aggravated her hypocalcemia symptoms. The echocardiogram showed global hypokinesia with an ejection fraction of 47%. After calcium and vitamin D replacement, her symptoms and ventricular function improved. Hypocalcemia needs to be considered in patients with heart failure, because it is readily reversible. To the best of our knowledge, this is the first report of a patient with heart failure and rhabdomyolysis induced by primary hypoparathyroidism during lactation.
Close layer
Intrathyroidal Metastasis of Lung Adenocarcinoma Presenting as Subacute Thyroiditis.
Hyun Sung Shin, Young Kwang Choo, Won Ae Lee, Hyun Kyung Chung
Endocrinol Metab. 2010;25(3):226-230.   Published online September 1, 2010
DOI: https://doi.org/10.3803/EnM.2010.25.3.226
  • 1,671 View
  • 19 Download
AbstractAbstract PDF
One of the rare diseases for differential diagnosis of subacute thyroiditis is metastases within the thyroid gland. We report here on a 72-year-old-woman with painful goiter and signs of hyperthyroidism. Her serum concentration of thyroid hormone was in the upper limit of normal, and the uptake of radioactive iodine by the thyroid was completely depressed. Although subacute thyroiditis was suspected, an additional work up that included a chest CT scan was done for the combined cough and chronic weakness. The result was lung cancer with metastatic involvement of the thyroid and multiple lymph nodes. She refused further anti-cancer therapy and died 5 months after the diagnosis. For the differential diagnosis of such a rare case, careful examination is important even in patients with the typical symptoms and laboratory findings of subacute thyroiditis.
Close layer
Spontaneous Pregnancy and Delivery in a Patient with Sheehan's Syndrome.
Young Kwang Choo, Won Sang Yoo, Do Hee Kim, Hyun Kyung Chung, Hee Jin Kim
J Korean Endocr Soc. 2009;24(2):121-125.   Published online June 1, 2009
DOI: https://doi.org/10.3803/jkes.2009.24.2.121
  • 1,738 View
  • 22 Download
  • 1 Crossref
AbstractAbstract PDF
Sheehan's syndrome is postpartum hypopituitarism due to the necrosis of the pituitary gland. It is usually the result of severe hypotension or shock caused by massive hemorrhage during or after delivery. Patients with Sheehan's syndrome have varying degrees of anterior pituitary hormone deficiency. They are accompanied with amenorrhea and ovulation dysfunction, and so they rarely get pregnant naturally. Ovulation induction is necessary if these patients desire to become pregnant. However, spontaneous pregnancy may be possible in some patients who have a preserved gonadotrophin reserve. We experienced a case of 29-year-old woman who was diagnosed Sheehan's syndrome 20 months after delivery and we medicated her with prednisolone and thyroxine. She got pregnant spontaneously after 18 months of hormone replacement therapy although she had amenorrhea and irregular menstrual cycles. She successfully delivered a baby by cesarean section. Here we report on this case with a review of the relevant literature concerned with pregnancy and Sheehan's syndrome.

Citations

Citations to this article as recorded by  
  • Acute Sheehan’s Syndrome Associated with Postpartum Hemorrhage
    Deokkyeong Kim, Jiwon Min, Yun-Sook Kim, Aeli Ryu
    Soonchunhyang Medical Science.2017; 23(1): 65.     CrossRef
Close layer
A Family of Multiple Endocrine Neoplasia Type 2A with a C634R Mutation and a G691S Polymorphism in RET Proto-oncogene.
Seoung Wook Yun, Won Sang Yoo, Koo Hyun Hong, Bae Hwan Kim, Min Ho Kang, Young Kwang Choo, Hee Yoon Park, Do Hee Kim, Hyun Kyung Chung, Myung Chul Chang, Mi Seon Kwon, Hee Jin Kim
J Korean Endocr Soc. 2007;22(6):453-459.   Published online December 1, 2007
DOI: https://doi.org/10.3803/jkes.2007.22.6.453
  • 1,865 View
  • 31 Download
  • 2 Crossref
AbstractAbstract PDF
Multiple endocrine neoplasia type 2A (MEN2A) is an autosomal dominant syndrome characterized by the presence of a medullary thyroid carcinoma, pheochromocytoma and hyperparathyroidism. MEN2A arises due to germline missense mutations of the RET proto-oncogene. Specific RET mutations correlate with the onset of age and the aggressiveness of a medullary thyroid carcinoma. However, the clinical presentation varies even within families, where patients carry the same mutation. Recently, it has been reported that polymorphisms of RET may have a modifier effect on the presentation. We experienced a case of 42-year-old man, whose bilateral pheochromocytoma and medullary thyroid carcinoma were incidentally found. Genetic testing detected a mutation in codon 634 (C634R) and a polymorphism in codon 691 (G691S) of the RET proto-oncogene. His mother, younger brother and his only son had the same mutation and polymorphism. We report this case with a review of the literature about RET gene polymorphisms.

Citations

Citations to this article as recorded by  
  • A Family Presenting with Catastrophic Features due to Pheochromocytoma Associated with Multiple Endocrine Neoplasia 2A
    Yun Jung Lee, Suk Chon, Sang-Ho Lee, Tae-Won Lee, Chun-Gyoo Ihm, Tae June Noh, Seungjoon Oh, Jeong-Taek Woo, Sung-Woon Kim, Jin-Woo Kim, Young Seol Kim
    Endocrinology and Metabolism.2010; 25(2): 135.     CrossRef
  • A Case of Sporadic Medullary Thyroid Cancer with RET G691S Polymorphism
    Min-Kyu Kang, Jung-Min Lee, Ji-Hyun Kim, Min-Young Lee, Ji Hyun Kim, Sung Dae Moon, Je-Ho Han, Sang-Ah Chang
    Journal of Korean Endocrine Society.2009; 24(4): 293.     CrossRef
Close layer
Original Articles
Effect of High Concentration of Estradiol on Thyroid Specific Genes Expression and Cell Growth.
Dong Woo Kim, Hee Youn Park, Do Hee Kim, Hee Jin Kim, Hyun Kyung Chung
J Korean Endocr Soc. 2006;21(1):32-39.   Published online February 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.1.32
  • 1,879 View
  • 25 Download
AbstractAbstract PDF
BACKGROUND
Since various thyroid diseases have dominant prevalence in women, it has been suggested that female sex hormone have important role on thyroid cell physiology. Interestingly, many thyroid disorders are newly diagnosed or changed their course around the period of high estrogen status, such as pregnancy. In this study, we questioned whether high concentration of estrogen could modulate thyroid cell function. METHODS: We treated normal rat thyroid FRTL-5 cell line with different time and concentration of estradiol. Using cell count, FACscan, and Northern blot analysis, we compared the changes of cell growth, cell cycle progression and thyroid specific genes expression. To evaluate the influence of thyroid stimulating hormone (TSH), all experiment was designed as two different sets, with (6H) or without TSH (5H). RESULTS: The concentration of 10-1000 nM estradiol had definite stimulatory function on thyroid cell growth in 5H condition as concentration dependent manner. FACscan revealed the increased cell growths were related to G1/S progression. The Pax-8, TTF-1 and NIS gene expressions were dramatically increased in 10-1000 nM of estradiol, too. With TSH (6H), however, we could not find any cell growth stimulating effects with 10-1000 nM of estradiol. CONCLUSION: High concentration of estradiol is one of important control factor for thyroid growth and thyroid specific genes expression, especially in 5H condition. It indicate that exposure to high concentration of female sex hormone, such as pregnancy, can be a direct stimulating factor to various thyroid function and related to autoimmune or nodular thyroid diseases around the period of pregnancy.
Close layer
Prevalence Thyroid Cancer in Patients with Cold Thyroid Nodules in Relation to Sex, Age, And Multinodularity.
Won Bae Kim, Hyun Kyung Chung, Chang Hoon Yim, Do Joon Park, Sung Yeon Kim, Bo Yeon Cho, Hong Gyu Lee
J Korean Endocr Soc. 1998;13(3):366-372.   Published online January 1, 2001
  • 1,133 View
  • 22 Download
AbstractAbstract PDF
BACKGROUND
We evaluated the prevalence of thyroid cancer in patients with cold thyroid nodules and the impact of sex, age, hardness of nodule, and multinodularity as factors able to predict the probability of malignancy in patients with nodular thyroid diseases. METHODS: We examined a 728 patients who visited Seoul National University Hospital with one or more cold thyroid nodules between Jan. 1996 and Dec. 1997. After clinical evaluations including medical history, physical examinations(size, hardness and multiplicity of nodule), fine needle aspiration biopsies and cytologic examinations were carried out. RESULTS: Among the 728 cases, 76 cases(10.4%) were diagnosed as cancer and 602 cases (82.6%) were diagnosed as benign nodule. The prevalence of cancer was significantly lower in female patients with cold nodules(9.4%, 62/662) than in males(17.5%, 11/63)(p=0.041). Age was an important factor in both sexes. The proportion of nodules that were malignant was lower in patients of 20-60 years old(8,9%, 56/632) than patients younger than 20 years old(1S.1%, 2/11) or older than 60 years old(18.3%, 15/82)(p=0.019). The prevalence of cancer was significantly higher in hard nodules(36.3%, 41/113) than firm(5.2%, 30/574) or soft nodules(5.3%, 2/38)(p= 0.001). There was no size difference between malignant(25.2 +- 13.7mm) and benign nodules(25.3 +- 8.9mm)(p=0.9425). The prevalence of thyroid cancer in solitary nodule(10.6%, 63/593) was not different from that in multiple nodules(7.6%, 10/132)(p=0.293). CONCLUSION: Our data suggest that thyroid nodules of the patients who are younger than 20 years old or older than 60 years old, male, as well as hard nodule require more careful evaluation for the risk of thyroid malignancies.
Close layer
Usefulness of Immunoglobulin Fraction Precipitated with Polyethylene Glycol in Assay for TSH Receptor Antibodies using Chinese Hamster Overy Cells Expressing Human TSH Receptors.
Won Bae Kim, Hyun Kyung Chung, Chang Soon Koh, Chang Hoon Yim, Do Joon Park, Bo Yeon Cho, Hong Gyu Lee
J Korean Endocr Soc. 1998;13(2):167-180.   Published online January 1, 2001
  • 1,067 View
  • 17 Download
AbstractAbstract PDF
BACKGROUND
Graves' disease and primary myxedema are thought to be caused by the action of TSH receptor autoantibodies(thyroid stimulating antibody; TSAb & thyroid stimulation blocking antibody; TSBAb). Thus, detection of these antibodies is crucial in diagnosis and in follow up of those patients. Recently, a sensitive method using human TSH receptor transfected Chinese Hamster Ovary(CHO) cells has been developed. However, the complexity of IgG purification procedure is considered as a limitation for its clinical application as a routine test. The aim of this study is to determine whether polyethylene glycol(PEG)-precipitated immunogiobuIin fraction could substitute for purified IgG. METHODS: We developed optimal conditions for TSAb and TSBAb assays using crude, PEG precipitated immunoglobulin fraction; and evaluated the correlation of TSAb and TSBAb activities between thase measured using crude immunoglobulin fraction and purified IgG to clarify the usefulness of PEG-precipitated immunoglobulin fraction. TSH receptor expressing wild type CHO cells were used in TSAb and CHO cells expressing chimeric TSH receptor(Mc2; 90-165 amino acid residues were substituted by those of rat LH/CG receptar) were used in TSBAb assay to minimize the possible disturbing effects of TSAb in serum. RESULTS: The optimal serum amount for TSAb and TSBAb assay using PEG-precipitated immunoglobulin fraction were 250mL serum equivalent/well and 50mL serum equivalent/well, respectively. The optimal incubation time for both assays were 2 homs, and aptimal ccrncentration of bTSH for TSBAb assay was 0.1U/L. TSAb activities measured with PEG-precipitated immunoglobulin were significantly correlated with those measured with purified IgG in 26 patients with Graves diseases(r=0.93, p<0.001). Although TSBAb activities measured using PEG-precipitated imrnunoglobulin were conelated with those measured using purified IgG in 20 patients with primary myxedema(r=0.86, p<0.001), the positive rate in TSBAb assay using PEG-precipitated immunoglobulin was lower than that of usmg purified IgG(20% v.s. 65%) because of negative conversion of TSBAb activities in samples with weakly positive TSBAb activities measured using purified IgG. CONCLUSION: PEG-precipitated immunoglobulin fraction could be used instead of purified IgG in TSAb assay using hTSHR-tranasfected wild type CHO cells with equal sensitivity and specificity. This simple and practical TSAb assay using PEG-precipitated immunoglobulin in hTSHR-transfected CHO cells would be useful in clinica1 practiee.
Close layer
Analysis of Prognostic Factors Determining the Recurrences in Patients with Papillary Thyroid Cancer After Surgical Treatment.
Jae Seok Jeon, Won Bae Kim, Hyun Kyung Chung, Bo Youn Cho, Hong Kyu Lee, Chang Soon Koh, Do Joon Park, Sun Wook Kim
J Korean Endocr Soc. 1997;12(3):421-432.   Published online January 1, 2001
  • 1,030 View
  • 19 Download
AbstractAbstract PDF
BACKGROUND
It is important to recognize the independent prognostic factors of papillary carcinoma of thyroid in therapeutic and follow up planning. However, its good prognosis and its low prevalence make it difficult to analyze prognostic factors determining patients survival in a relatively short period of time. We retrospectively investigated the independent prognostic factors for determining disease recurrence after surgery which, in adults, are known to be closely related to the prognosis of cancer. METHOD: We retrospectively reviewed the clinical records of 456 patients (male 70, female 381, unknown 5, mean age of 43.9+-12.9 years) who had visited the thyroid clinic in Seoul National University Hospital and analyzed the data with statistical software program. RESULTS: 1) At initial visit, chief complaint of the patients was abnormal neck mass in 90 percent. 2) In preoperative thyroid scan study, 82% showed cold area and 16% showed diffuse enlargement. 3) Of the 50 recurrent cases after surgery (11.5% of the total cases), 39 cases (78%) had recurred disease in neck area and 11 cases (22%) had recurrences at distant sites. (Lung 9 cases, Brain I case, Mediastinum 1case) 4) Statistically significant risk factors for recurrence after surgery were male sex, size of tumor (above 4.5cm in this study), extrathyroidal invasion of cancer, involvement of resection margin and no remnant ablation of thyroid tissue using radioiodine. CONCLUSION: Through retrospective study, we presented some clinical characteristics of papillary thyroid cancer in Korea and independent risk factors of cancer recurrences after surgery.
Close layer
Changes in Properties of Thyrotropin Receptor Antibodies Following Radioiodine Treatment in Patients with Graves' Disease.
Won Bae Kim, Hyun Kyung Chung, Bo Youn Cho, Hong Kyu Lee, Chang Soon Koh, Do Joon Park, Yeon Sahng Oh
J Korean Endocr Soc. 1997;12(2):194-206.   Published online January 1, 2001
  • 1,128 View
  • 16 Download
AbstractAbstract PDF
BACKGROUND
It has been suggested that thyroid stimulation blocking antibody (TSBAb) is involved in the development of early hypothyroidism after radioiodine treatment in patient with Graves disease. However, previous studies have reported the effect of radioiodine treatment on overall changes of TSH receptor antibodies without detailed observation of changes in properties of TSH receptor antibodies. The aim of this study is to evaluate the effect of radioiodine treatment on thyroid stimulation antibody (TSAb) or on thyroid stimulation blocking antibody (TSBAb) activities and to see whether the appearance of TSBAb after radioiodine treatment is involved in the development of early hypothyroidism in patients with Graves disease. METHODS: The activities of TSAb, TSBAb were measured serially with human TSH receptor transfected Chinese hamster ovary (CHO) cells in 36 patients with Graves disease who received 131I treatment. In addition to the wild type TSH receptor-expressing cells, we used a chimeric receptor that 90-165 amino acid residues were substituted by those of rat LH/CG receptor (Mc2) for measurement of TSBAb without interference by the presence of TSAb and for evaluation of TSAb epitope spreading. We evaluated the association of early hypothyroidism after 131I treatment with changes of various immunologic parameters. RESULTS: In 14 (39%) of 36 patients, TSBAb activities were present in their sera before or after 131I treatment. Four of them had TSBAb activities before 131 treatment, and 12 newly acquired TSBAb activities after 131I treatment. The existence of TSBAb was not associated with the development of early hypothyroidism after 131I treatment but with low TSAb activities before 131 treatment, high thyroidal uptake of 131I given and with old age. The phenomena of epitope spreading measured by TSAb with Mc2 mutant clone before and after 131I treatment was not infrequent, but it had no clinical relevance. CONCLUSION: These results suggest that the existence of TSBAb may be not a major factor in the development of early hypothyroidism after radioiodine treatment in Graves disease. Other factors such as TSAb activities before radioiodine treatment, the efficiency of thyroidal uptake of 131I or old age are associated with the development of early hypothyroidism.
Close layer

Endocrinol Metab : Endocrinology and Metabolism